Paul Stacey
Director of Finance/CFO at GABY INC.
Net worth: 1 667 $ as of 30/03/2024
Profile
Paul Stacey is currently the Chief Financial Officer & Vice President at GABY, Inc. He previously worked as the Chief Financial Officer at Metagreen and The Hempshire Group, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GABY, INC.
0.05% | 19/06/2023 | 333,333 ( 0.05% ) | 1 667 $ | 30/03/2024 |
Paul Stacey active positions
| Companies | Position | Start |
|---|---|---|
| GABY INC. | Director of Finance/CFO | 28/02/2022 |
Former positions of Paul Stacey
| Companies | Position | End |
|---|---|---|
| THE HEMPSHIRE GROUP, INC. | Director of Finance/CFO | 13/02/2024 |
Metagreen
 Metagreen Pharmaceuticals: OtherHealth Technology Metagreen provides health care and pharmaceutical technology services. It develops novopure technology for extraction and clarionworks technology for purification and formulations. The company was founded by Randall B. Murphy in 2015 and is headquartered in Los Angeles, CA. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GABY INC. | Consumer Non-Durables |
| THE HEMPSHIRE GROUP, INC. | Consumer Non-Durables |
| Private companies | 1 |
|---|---|
Metagreen
Metagreen Pharmaceuticals: OtherHealth Technology Metagreen provides health care and pharmaceutical technology services. It develops novopure technology for extraction and clarionworks technology for purification and formulations. The company was founded by Randall B. Murphy in 2015 and is headquartered in Los Angeles, CA. | Health Technology |
- Stock Market
- Insiders
- Paul Stacey
